Sustained Exosome-Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and miRNAs, and Sustained Release Formulation

    March 2022 in “ Small
    Gijung Kwak, Jing Cheng, Hyo‐Suk Kim, Sukyung Song, Su Jin Lee, Yoosoo Yang, Ji Hoon Jeong, Ji Eun Lee, Phillip B. Messersmith, Sun Hwa Kim
    New to Exosomes? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In an animal model, this study found that PEG hydrogels delivering M2 macrophage-derived exosomes effectively promoted M1 to M2 macrophage transition and enhanced wound healing.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigated the use of exosomes, specifically M2-derived exosomes (M2-Exos), in wound healing. M2-Exos can reprogram M1 macrophages to M2, aiding in the transition from inflammation to proliferation during wound healing. To overcome the rapid clearance of exosomes from the body, a hydrogel system was developed to encapsulate M2-Exos and control their release over 6 to 26 days. This system improved wound closure and healing quality in a mouse model by promoting the conversion of M1 to M2 macrophages at the wound site. The study also identified protein and miRNA signatures of M1- and M2-Exos through proteomic and genomic sequencing analysis. The researchers developed a novel M2-Exo-loaded hydrogel system for a sustained supply of a high dose of exosomes to promote the M1-to-M2 macrophage transition in the wound area. The study suggests that tailoring M-Exo release rates in hydrogel-based delivery applications offers a promising therapeutic strategy for various inflammation-related diseases.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results